You searched for "MIGS"
Best way to detect glaucoma progression: by reflecting on the past 25 years
1 June 2018
| Leon Au, Cecilia Fenerty
|
EYE - Glaucoma
Glaucoma – a condition of optic neuropathy leading to progressive visual field loss often associated with raised intraocular pressure. It is fair to say that our definition for this condition has remained unchanged over the last 25 years and the...
Clinical and management strategies in glaucoma practice: perspectives from international glaucoma specialists
1 April 2015
| Keith Barton, Winifred Nolan, Nick Strouthidis
|
EYE - Glaucoma
Management options and outcomes in glaucoma practice were reviewed at the 7th Moorfields International Glaucoma Symposium, held in London on 24 January 2015. This article summarises perspectives from international glaucoma specialists on debated issues in topical therapy, glaucoma surgery, diagnostic...
Impact of WASH factors on trachoma prevalence
4 December 2024
| Nishita Patel
|
EYE - Cornea
Trachoma is the leading infectious cause of blindness globally. Following a national population-based trachoma survey in Malawi, one round of azithromycin mass drug elimination (MDA) was carried out successfully – that is, the prevalence of trachomatous inflammation, follicular (TF) in...
Tear film thickness after treatment with artificial tears in patients with moderate dry eye disease
In recent years artificial tear drops addressing tear film osmolarity have come onto the market. Increased tear evaporation and reduced tear volume results in tear hyperosmolarity. This triggers an inflammatory process leading to apoptosis of goblet and epithelial cells. Trehalose,...
Transcanalicular diode laser-assisted DCR: success rates and factors for success
This study aimed to evaluate the success rates of transcanalicular diode laser-assisted dacryocystorhinostomy (TCL-DCR) during three years of follow-up and to find clinical factors that influence surgical outcomes. Major outcomes were defined as a patent neo-ostium tested by irrigation (anatomical...Ciliatech presents preliminary results on treating glaucoma with CID at Ophthalmology Futures Symposium
Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.Landmark review of glaucoma treatment and research published by Moorfields-led team
Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.What’s new in glaucoma? Clinical trials drive practice changes, surgical advancements gather pace
Rod McNeil reviews the latest developments in the treatment of glaucoma in the UK. Primary open-angle glaucoma (POAG), which accounts for over two-thirds of all glaucoma cases, has an estimated UK prevalence in 2017 of approximately 2% of people over...In conversation with John Forrester
2 December 2019
| Hari Kaneshayogan
|
EYE - General
What made you choose ophthalmology as a career and how did your interest in academia develop? During Medical School at Glasgow University, I was getting progressively disillusioned with the career options while my colleagues and friends all seemed to quickly...
An interview with Professor John Forrester
2 December 2019
| Hari Kaneshayogan
|
EYE - General
What made you choose ophthalmology as a career and how did your interest in academia develop? During Medical School at Glasgow University, I was getting progressively disillusioned with the career options while my colleagues and friends all seemed to quickly...
UK ophthalmologists discuss value of ultra-widefield multimodality retinal imaging
Utilising optomap ultra-widefield (UWF™) multimodality retinal imaging with integrated SS (or SD) OCT in clinical practice contributes to identifying unexpected pathologies in a patient without visual complaints, report 81% of clinicians at industry webinar.2030 IN SIGHT LIVE, Nepal
29 April 2025
-1 May 2025
2030 IN SIGHT LIVE is your exclusive platform to drive tangible progress towards universal eye health. Join us in Kathmandu for an immersive experience that fosters collaboration, ignites leadership, and empowers advocacy. Building upon the success of our events in...
